Fig. 2From: Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizationsLevels of agreement with statements about trial site selection in the Nordic countries # This question applied to only biopharmaceutical respondents (n = 43) ¤ This question applied to only CRO respondents (n = 40). CRO clinical research organizationBack to article page